Georgia (the US state) permits registered patients to possess low-THC oil containing no more than 5% THC under the Georgia Hope Act (originally Haleigh's Hope Act, 2015, amended 2019 via HB 324). Qualifying conditions include cancer, ALS, seizure disorders, multiple sclerosis, Crohn's disease, Parkinson's disease, PTSD, sickle cell disease, chronic pain, fibromyalgia, and autism spectrum disorder. Patients may possess up to 20 fluid ounces of low-THC oil and, since 2021 (SB 195), may also purchase tinctures, transdermal patches, lotions, and capsules. The Georgia Access to Medical Cannabis Commission oversees in-state production licensing and dispensary operations. Smoking and edibles remain prohibited. A House study committee convened in 2025 to examine potential expansion of the medical program.
Ask the Expert about GeorgiaO.C.G.A. § 16-12-190 et seq. (Georgia's Hope Act, formerly Haleigh's Hope Act)
Georgia Access to Medical Cannabis Commission (GMCC)